Nephrology Fellowship

Nephrology Fellowship

OVERVIEW

Thank you for your interest in the Nephrology Fellowship Program at Jacobi Medical Center/Albert Einstein College of Medicine. Jacobi Medical Center is part of the North Bronx Healthcare Network, whose mission is to provide quality, cost effective primary and acute care services to our community in a respectful, professional manner, regardless of the ability to pay. In the Nephrology Division, we offer a comprehensive two year training program that comprises strong clinical nephrology complemented with patient-oriented research.

Our program accepts two fellows each year. First-year fellows divide their time equally between the inpatient clinical services at Jacobi Medical Center and North Central Bronx Hospital.  They also spend ½ day each week in a continuity ambulatory experience which continues into their second year. In addition to clinical consult service rotations, the second year comprises of two months of transplant nephrology, electives and provides opportunities for research. In addition, next year we are introducing a cardio renal clinical track in the second year. This will consist of 4 months of cardiology exposure in the second year, offering nephrology training with clinical focus in cardiology. Cardiology exposure will come in the form of rotations in cardiac care unit (CCU), Non- invasive cardiology testing-echocardiography/cardiac stress testing, cardiology consults, heart failure clinics, and a short, dedicated period of cardiorenal research. Fellows will be introduced to the outpatient hemodialysis center at Pelham Parkway Dialysis Unit located on Jacobi campus. The diverse patient population and the large volume provide a great wealth of clinical experience.  Patients and staff are also able to benefit from Jacobi’s new state-of-the art in-patient and out-patient facilities.  A combination of a hands-on learning environment, supervised autonomy, and uninterrupted didactic teaching make for an invaluable opportunity to learn Nephrology.

FELLOWSHIP GOALS 

The goal of the fellowship is to provide outstanding training in all aspects of nephrology in a nurturing academic environment including both inpatient and outpatient settings.

During the inpatient rotations, fellows will be trained in the diagnosis and management of acute kidney injury in various hospital settings, critical care nephrology, glomerular and tubulointerstitial kidney diseases, fluid-electrolyte disorders, hypertension, pregnancy related kidney diseases, chronic kidney disease and end-stage kidney disease, kidney stones, and various other renal disorders. They will also become proficient in performing the procedures such as urinalysis, temporary vascular access for dialysis and US guided kidney biopsy.

The outpatient experience will allow the fellows to have abundant exposure to the outpatient management of renal disease during their weekly continuity clinic at Jacobi Medical Center. They also attend the renal clinic at North Central Bronx which is mainly a community hospital setting. In addition, the fellowship program is affiliated with Columbia Presbyterian Medical Center for transplant nephrology which ensures an enriching learning experience in this field. During the transplant rotations at Columbia Presbyterian Hospital the fellows have the opportunity to attend transplant clinics.  In the second year, the fellows also spend two weeks doing renal pathology in the world - renowned pathology division at Columbia Presbyterian Medical Center.

Clinical Rotations

First Year

  • Jacobi Medical Center in-patient service
  • Continuity clinic (one-half day per week)
  • North Central Bronx Hospital Clinic experience
  • Vacation (As per contract)
  • Electives (two 2-week blocks)
    • Interventional radiology
    • Vascular surgery
    • Pediatric nephrology
    • Urology
    • New 2021: Interventional Radiology
    • New 2022: Renal Ultrasound
    • Research exploration

Second Year

  • Jacobi Medical Center in-patient service
  • NEW: Cardiac Care Unit (CCU) 4 weeks
  • Continuity clinic (one-half day per week)
  • North Central Bronx Hospital Clinic experience
  • NEW 2023: CHF/Cardio renal clinic (4 months)
  • Research
    • Clinical
    • Translational
  • Electives (two 2-week blocks)
    • Renal pathology
    • Vascular surgery
    • Interventional radiology
    • Pediatric nephrology
    • Urology
    • Radiology/Renal Ultrasound

 

  • Vacation (as per contract)
  • Jacobi Medical Center/North Central Bronx in-patient service (two 2-week blocks)
  • Transplant Nephrology at Columbia Presbyterian Medical Center (two months)
  • Out-patient Hemodialysis at Pelham Parkway Dialysis Unit (one shift of about 25 patients weekly

Cardiorenal Track - 2023

We are excited to be introducing the cardio renal track in the second year of training!
CKD has been linked with heart failure and cardio vascular disease. „ People often have both heart disease and CKD. These conditions share many of the same risk factors, including diabetes and high blood pressure. The intricacies between the heart and kidney, their relationship to one another is becoming better defined. Though this paradigm of integrative physiology cardiorenal medicine is emerging as a distinct focus.
We will be offering nephrology training with clinical focus in cardiology in the second year.
Cardiology exposure comes in the form of rotations in cardiac care unit (CCU), non- invasive cardiology testing-echocardiography/cardiac stress testing, catheterization lab, cardiology consults, heart failure exposure in CHF clinics, and a short dedicated period of cardiorenal research. This will aid you to become a nephrologist well trained with clinical focus in cardiorenal patients. This skill will enable you to take care of these complex patients as the lines between cardiology and nephrology begin to blur especially in those with CHF. Evidence suggests that combined cardiology-nephrology clinics may help improve management of patients with HF and CKD. A multidisciplinary approach will help in implementation of evidence-based therapy in these very complex patients.

Cardio renal track will consist of the following rotations in the second year of fellowship:
1 month-CCU
I month-ECHO/non- invasive stress test
I month- CHF/ Cardio renal clinic and cardiology consult
1 Month- Cardiac catheterization Lab and cardiology consults

Outpatient Experience

• Renal ambulatory continuity clinic at Jacobi Medical Center (continuity clinic)
• Renal ambulatory clinic at North Central Bronx Hospital
• Transplant clinic at Columbia Presbyterian Hospital Medical Center (second year)
• Out-patient Hemodialysis Unit (second year)

Conferences

Our educational program includes an extensive conference series that offers core knowledge, ongoing updates in nephrology. Attendance is mandatory for all fellows unless they are on an off-site rotation. Fellows are given protected time to attend conference and they are relieved from clinical duty during those times.
• Medicine grand rounds (weekly)
• Clinical conference (weekly)
• Journal club (monthly)
• Renal pathology conference at Columbia Presbyterian Medical Center (twice monthly)
• Core lecture series by Faculty
• Extensive hands on and didactic sessions on use of POCUS

Procedures

Fellows will have ample opportunity to develop their skills performing the following procedures.
Urinalysis
• US guided Placement of temporary dialysis catheters
• US guided Percutaneous renal biopsies of native and transplanted kidneys
• Acute and chronic hemodialysis
• Continuous renal replacement therapy (CRRT)
• Peritoneal dialysis
• Home hemodialysis

Faculty

Anjali Acharya, MD

Professor of Medicine, Albert Einstein College of Medicine
Program Director, Nephrology Fellowship

Chief of Nephrology Division-Jacobi and North Central Bronx
anjali.acharya@nychhc.org

Naheed Ansari, MD
Associate Professor of Medicine
Albert Einstein College of Medicine
On-site Director, North Central Bronx Hospital
naheed.ansari@nychhc.org

Belinda Jim, MD
Professor of Medicine, Albert Einstein College of Medicine
Associate Program Director
bun.jim@nychhc.org

Kisra Anis, MD
Assistant Professor of Medicine, Albert Einstein College of Medicine
Medical Director, Pelham Parkway Dialysis Unit
kisra.anis@nychhc.org

Michal Packman, MD
Assistant Prof of Medicine, Albert Einstein College of Medicine
michal.packman@nychhc.org

Nidhi Varma , MD
Assistant Prof of Medicine, Albert Einstein College of Medicine
Varman@nychhc.org

How To Apply

All applications are accepted exclusively though ERAS.

Incomplete applications will not be reviewed; USMLE scores, a complete CV, a personal statement, 3 letters of recommendation, a medical school transcript, and an MSPE from your medical school are all required. We suggest that you get these all in to ERAS as soon as possible in order to ensure that your file is reviewed as early in the season as possible.

Foreign Medical Graduates requesting H-1 and J-1 Visas are considered.

Research

Faculty areas of interest:

Obstetric Nephrology-Biomarkers in Preeclampsia and AKI in pregnancy

Cardio renal syndromes-Biomarkers in CRS

Optimal management of CHF in CKD

COVID-AKI

Multi center sponsored studies in the last 10 years:

  1. An Observer-blinded randomized study comparing the safety and immunogenicity of HEPLISAV to licensed vaccine (Engerix-B) among adults (18 to 70 years of age) with CKD
  2. An observational study evaluating the long-term safety and immunogenicity of HEPLISAV compared to Engerix-B in adults with CKD who have previously received at least one hepatitis B vaccine series
  3. START-CKD: Strategies using Darbepoetin alfa to avoid transfusions in CKD
  4. BEACON: Bardoxolone Methyl evaluation in patients with CKD and type 2 diabetes: the occurrence of renal events
  5. A phase 2 randomized double-blind placebo-controlled parallel-group multicenter study to evaluate the efficacy and safety of once daily administration of phosphodiesterase 5 inhibitor (PF-00489791) in adults with type 2 diabetes and overt nephropathy
  6. SALACIA: A phase 3b multicenter randomized single-blind parallel group trial of the effects of titrated oral SAMSCA (Tolvaptan) 15,30, 60 mg QD compared to placebo plus fluid restriction on length of hospital stay and symptoms in subjects hospitalized with dilutional hyponatremia
  7. DIRECT: The genetic contribution to drug induced renal injury: the drug induced renal injury consortium
  8. PHOENIX: A phase 2 trial of the safety and efficacy of Bardoxolone Methyl in patients with rare CKDs
  9. ISCHEMIA: International study of comparative health effectiveness with medical and invasive approaches

NIH (through NYU)

  1. A phase 3 randomized double-blind placebo-controlled study of the efficacy and safety of Roxadustat (FG-4592) for the treatment of anemia in CKD patients not on dialysis
  2. DIAMOND: A multicenter double-blind placebo-controlled randomized withdrawal parallel-group study of Patiromer for the management of hyperkalemia in subjects receiving Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) medications for the treatment of heart failure
  3. GS-US-540-5912: A phase 3 randomized double-blind placebo-controlled parallel-group multicenter study evaluating the efficacy and safety of Remdesivir in participants with severely reduced kidney function who are hospitalized for COVID-19
  4. A multicenter randomized double-blind parallel-group placebo-controlled study to assess safety, tolerability, pharmacokinetics and pharmacodynamics of BI 764198 administered orally once daily for 12 weeks in patients with FSGS
  5. Epidemiology of AKI in the ICU (ongoing)